Investori
Overview
Financial reporting
Risk management
Reporting standards
Auditors
Governance
IR policy
Management
Board of directors
Annual general meeting
Annual general meeting (DK)
News & Events
Company releases
Company releases (DK)
Webcasts & presentations
Investor calendar
The Share
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme
Contact IR
Management
Board of directors
AGM
AGM (DK)
Kontakt
Kontaktné informácie
Nahlásenie nežiadúcich účinkov
Fulltext search
Search
New data from GAP landmark trial confirms GRAZAX® prevents asthma symptoms in children
Monday, June 13, 2016
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=715…
Nasdaq ID:
1467136
Last updated:
2016.09.07
